Immunomodulation by mercuric chloride in vitro: Application of different cell activation pathways

Clinical and Experimental Immunology

Volumn 148, Issue 2, 2007, Pages 325-337

  Hemdan, N Y A ^a,b,c,e   Lehmann, I ^b   Wichmann, G ^b   Lehmann, J ^d   Emmrich, F ^a   Sack, U ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^c Alexandria University Faculty Of Science   (Egypt)

^d FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^e Institut für Klinische Immunologie und Transfusionsmedizin   (Germany)

Author keywords

Cellular activation; Helper T cells; Immunotoxicity; Inflammation; Mercuric chloride

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MERCURIC CHLORIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY CD40; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL ISOLATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; IMMUNOTOXICITY; INFLAMMATION; LEUKOCYTE ACTIVATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SEROTYPE; TH1 CELL; TH2 CELL; TOXICITY TESTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MERCURIC CHLORIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA ENTERITIDIS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 34247132194     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03338.x     Document Type: Article

References (84)

1. Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110 (Suppl. 1):11-23.
2. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury -current exposures and clinical manifestations. N Engl J Med 2003; 349:1731-7.
3. Enestrom S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 1995; 106:180-203.
4. Tchounwou PB, Ayensu WK, Ninashvili N, Sutton D. Environmental exposure to mercury and its toxicopathologic implications for public health. Environ Toxicol 2003; 18:149-75.
5. Sweet LI, Zelikoff JT. Toxicology and immunotoxicology of mercury: a comparative review in fish and humans. J Toxicol Environ Health B Crit Rev 2001; 4:161-205.
6. Havarinasab S, Hultman P. Organic mercury compounds and autoimmunity. Autoimmun Rev 2005; 4:270-5.
7. Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect 2003; 111:1273-7.
8. Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol 2005; 207:282-92.
9. Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 2006; 21:105-17.
10. Hultman P, Taylor A, Yang JM, Pollard KM. The effect of xenobiotic exposure on spontaneous autoimmunity in (SWR x SJL) F1 hybrid mice. J Toxicol Environ Health A 2006; 69:505-23.
11. World Health Organization (WHO). Evaluation of Certain Food Additives and Contaminants. Twenty-second report of the joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series. Geneva: WHO, 1978:1-39.
12. US Environmental Protection Agency (EPA). Mercury Study Report to Congress, Office of Air Quality Planning & Standards and Office of Research and Development, Volume IV: an Assessment of Exposure to Mercury in the United States. EPA-452/R-97-006, 1997. http://www.epa.gov/ttn/oarpg/t3/reports/volume4. pdf
13. Ip P, Wong V, Ho M, Lee J, Wong W. Environmental mercury exposure in children: South China's experience. Pediatr Int 2004; 46:715-21.
14. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci 1997; 34:369-403.
15. Mitchell RJ, Osborne PB, Haubenreich JE. Dental amalgam restorations: daily mercury dose and biocompatibility. J Long Term Effect Med 2005; 15:709-21.
16. Hultman P, Enestrom S. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol Appl Pharmacol 1992; 113:199-208.
17. Yoshida M, Watanabe C, Satoh M et al. Susceptibility of metallothionein-null mice to the behavioral alterations caused by exposure to mercury vapor at human-relevant concentration. Toxicol Sci 2004; 80:69-73.
18. Warfvinge K, Hansson H, Hultman P. Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol 1995; 132:299-309.
19. Havarinasab S, Lambertsson L, Qvarnstrom J, Hultman P. Dose - response study of thimerosal-induced murine systemic autoimmunity. Toxicol Appl Pharmacol 2004; 194:169-79.
20. Echeverria D, Woods JS, Heyer NJ et al. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol 2006; 28:39-48.
21. Woods JS, Echeverria D, Heyer NJ, Simmonds PL, Wilkerson J, Farin FM. The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 2005; 206:113-20.
22. Hemdan NYA, Emmrich F, Adham K et al. Dose-dependent modulation of the in vitro cytokine production of human immune competent cells by lead salts. Toxicol Sci 2005; 86:75-83.
23. Haggqvist B, Hultman P. Murine metal-induced systemic autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains. Clin Exp Immunol 2001; 126:157-64.
24. Shen X, Lee K, Konig R. Effects of heavy metal ions on resting and antigen-activated CD4(+) T cells. Toxicology 2001; 169:67-80.
25. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
26. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991; 12:A49-A53.
27. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
28. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991; 12:256-7.
29. Umetsu DT, Jabara HH, DeKruyff RH, Abbas AK, Abrams JS, Geha RS. Functional heterogeneity among human inducer T cell clones. J Immunol 1988; 140:4211-6.
30. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-44.
31. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 2000; 164:4878-82.
32. Seder RA, Paul WE, Davis MM, Fazekas DS. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992; 176:1091-8.
33. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
34. Hultman P, Johansson U, Dagnaes-Hansen F. Murine mercury-induced autoimmunity: the role of T-helper cells. J Autoimmun 1995; 8:809-23.
35. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 1998; 9:139-51.
36. Lawrence DA, McCabe MJ Jr. Immunomodulation by metals. Int Immunopharmacol 2002; 2:293-302.
37. Haggqvist B, Hultman P. Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin Exp Immunol 2003; 134:202-9.
38. Gleichmann E, Kimber I, Purchase IF. Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion. Arch Toxicol 1989; 63:257-73.
39. Haggqvist B, Hultman P. Interleukin-10 in murine metal-induced systemic autoimmunity. Clin Exp Immunol 2005; 141:422-31.
40. Hansson M, Djerbi M, Rabbani H et al. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1mice. Immunology 2005; 114:428-37.
41. Havarinasab S, Haggqvist B, Bjorn E, Pollard KM, Hultman P. Immunosuppressive and autoimmune effects of thimerosal in mice. Toxicol Appl Pharmacol 2005; 204:109-21.
42. Vimercati L, Santarelli L, Pesola G et al. Monocyte-macrophage system and polymorphonuclear leukocytes in workers exposed to low levels of metallic mercury. Sci Total Environ 2001; 270:157-63.
43. Shenker BJ, Berthold P, Decker S et al. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. II. Alterations in cell viability. Immunopharmacol Immunotoxicol 1992; 14:555-77.
44. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ Jr. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol Sci 2000; 56:255-61.
45. Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, Depierre JW, Hassan M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin Exp Immunol 2005; 141:238-47.
46. Hansteen IL, Ellingsen DG, Clausen KO, Kjuus H. Chromosome aberrations in chloralkali workers previously exposed to mercury vapor. Scand J Work Environ Health 1993; 19:375-81.
47. Mabille V, Roels H, Jacquet P, Leonard A, Lauwerys R. Cytogenetic examination of leucocytes of workers exposed to mercury vapour. Int Arch Occup Environ Health 1984; 53:257-60.
48. Loftenius A, Sandborgh-Englund G, Ekstrand J. Acute exposure to mercury from amalgam: no short-time effect on the peripheral blood lymphocytes in healthy individuals. J Toxicol Environ Health A 1998; 54:547-60.
49. Sandborgh-Englund G, af Geijersstam E, Loftenius A. Rapid communication: acute exposure to mercury from dental amalgam does not affect the levels of C-reactive protein or interleukin-6 in peripheral blood. J Toxicol Environ Health A 2003; 66:495-9.
50. Issa Y, Watts DC, Duxbury AJ, Brunton PA, Watson MB, Waters CM. Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line MO3.13. Biomaterials 2003; 24:981-7.
51. Luglie PF, Campus G, Chessa G et al. Effect of amalgam fillings on the mercury concentration in human amniotic fluid. Arch Gynecol Obstet 2005; 271:138-42.
52. Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE. Amalgam exposure and neurological function. Neurotoxicology 2005; 26:241-55.
53. Yamada H, Koizumi S. Metallothionein induction in human peripheral blood lymphocytes by heavy metals. Chem Biol Interact 1991; 78:347-54.
54. Shenker BJ, Rooney C, Vitale L, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. I. Suppression of T-cell activation. Immunopharmacol Immunotoxicol 1992; 14:539-53.
55. Shenker BJ, Berthold P, Rooney C, Vitale L, DeBolt K, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. III. Alterations in B-cell function and viability. Immunopharmacol Immunotoxicol 1993; 15:87-112.
56. Steffensen IL, Mesna OJ, Andruchow E, Namork E, Hylland K, Andersen RA. Cytotoxicity and accumulation of Hg, Ag, Cd, Cu, Pb and Zn in human peripheral T and B lymphocytes and monocytes in vitro. Gen Pharmacol 1994; 25:1621-33.
57. Lawrence DA. In vivo and in vitro effects of lead on humoral and cell-mediated immunity. Infect Immun 1981; 31:136-43.
58. Koller LD, Exon JH, Brauner JA. Methylmercury: decreased antibody formation in mice. Proc Soc Exp Biol Med 1977; 155:602-4.
59. Lawrence DA. Heavy metal modulation of lymphocyte activities. 1. In vitro effects of heavy metals on primary humoral immune responses. Toxicol Appl Pharmacol 1981; 57:439-51.
60. Lawrence DAS, Mudzinski U, Rudofsky G, Warner. Mechanisms of metal-induced immunotoxicity. In: Berlin A, Dean J, Draper MH, Smith EMB, Spreafico F, eds. Immunotoxicology. Dordrecht: Martinus-Nigoff, 1987:293-307.
61. Loftenius A, Ekstrand J, Moller E. HgCl(2)-induced human lymphocyte activation in vitro: a superantigenic mechanism? Int Arch Allergy Immunol 1999; 120:63-70.
62. Bencko V, Wagner V, Wagnerova M, Ondrejcak V. Immunological profiles in workers occupationally exposed to inorganic mercury. J Hyg Epidemiol Microbiol Immunol 1990; 34:9-15.
63. Johansson U, Hansson-Georgiadis H, Hultman P. The genotype determines the B cell response in mercury-treated mice. Int Arch Allergy Immunol 1998; 116:295-305.
64. Badou A, Savignac M, Moreau M et al. HgCl2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through 1-type calcium channels. J Biol Chem 1997; 272:32411-8.
65. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunologic Res 1999; 20:67-78.
66. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity. insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:223-7.
67. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146:3006-11.
68. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 1996; 138:149-57.
69. Heo Y, Lee WT, Lawrence DA. In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities. Cell Immunol 1997; 179:185-95.
70. Fournie GJ, Saoudi A, Druet P, Pelletier L. Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. Autoimmun Rev 2002; 1:205-12.
71. Soleo L, Vacca A, Vimercati L et al. Minimal immunological effects on workers with prolonged low exposure to inorganic mercury. Occup Environ Med 1997; 54:437-42.
72. Strenzke N, Grabbe J, Plath KE, Rohwer J, Wolff HH, Gibbs BF. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils. Toxicol Appl Pharmacol 2001; 174:257-63.
73. Gillespie KM, Qasim FJ, Tibbatts LM, Thiru S, Oliveira DB, Mathieson PW. Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol 1995; 41:268-72.
74. Prigent P, Saoudi A, Pannetier C et al. Mercuric chloride, a chemical responsible for T helper cell (Th) 2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest 1995; 96:1484-9.
75. Johansson U, Sander B, Hultman P. Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun 1997; 10:347-55.
76. Gochfeld M. Cases of mercury exposure, bioavailability, and absorption. Ecotoxicol Environ Saf 2003; 56:174-9.
77. Counter SA, Buchanan LH, Ortega F, Laurell G. Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines. J Toxicol Environ Health A 2002; 65:149-63.
78. Kingman A, Albertini T, Brown LJ. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998; 77:461-71.
79. Ganss C, Gottwald B, Traenckner I et al. Relation between mercury concentrations in saliva, blood, and urine in subjects with amalgam restorations. Clin Oral Invest 2000; 4:206-11.
80. Silva-Pereira LC, Cardoso PC, Leite DS et al. Cytotoxicity and genotoxicity of low doses of mercury chloride and methylmercury chloride on human lymphocytes in vitro. Braz J Med Res 2005; 38:901-7.
81. Lerch M, Bircher AJ. Systemically induced allergic exanthem from mercury. Contact Dermatitis 2004; 50:349-53.
82. Röger J, Zillikens D, Hartmann A, Burg G. Systemic autoimmune disease in a patient with long-standing exposure to mercury. Eur J Dermatol 1992; 2:168-70.
83. Dubey C, Bellon B, Druet P. TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals. Eur Cytokine Netw 1991; 2:147-52.
84. Nielsen JB, Hultman P. Mercury-induced autoimmunity in mice. Environ Health Perspect 2002; 110 (Suppl. 5):877-81.